InVivoMAb anti-mouse IL-12 p75
BE0233
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-12 p75
- Delivery Days Customer7
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDR2-9A5
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Ponzetta A, Carriero R, Carnevale S, et al. Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors. Cell. 2019,178(2):346-360.e24. doi: 10.1016/j.cell.2019.05.047Read this paper
- Everts B, Tussiwand R, Dreesen L, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016,213(1):35-51. doi: 10.1084/jem.20150235Read this paper
- Ruffell B, Chang-Strachan D, Chan V, et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell. 2014,26(5):623-37. doi: 10.1016/j.ccell.2014.09.006Read this paper
- Zheng R, Cohen PA, Paustian CA, et al. Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Res. 2008,68(11):4045-9. doi: 10.1158/0008-5472.CAN-07-6669Read this paper
- Pascual DW, Trunkle T, Sura J. Fimbriated Salmonella enterica serovar typhimurium abates initial inflammatory responses by macrophages. Infect Immun. 2002,70(8):4273-81.Read this paper
